Since cold exposure or pharmaceutical therapy to activate BAT by has been reported to increase circulating IL-6 and play beneficial roles in lipid metabolism and NAFLD by enhancing thermogenesis and increasing energy expenditure 28. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.